Association between Age at Diagnosis of Graves' Disease and Variants in Genes Involved in Immune Response

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Jurecka Lubieniecka, Beata ^a   Ploski, Rafal ^b   Kula, Dorota ^a   Krol, Aleksandra ^a   Bednarczuk, Tomasz ^b   Kolosza, Zofia ^a   Tukiendorf, Andrzej ^a   Szpak Ulczok, Sylwia ^a   Stanjek Cichoracka, Anita ^c   Polanska, Joanna ^d   Jarzab, Barbara ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CD40 GENE; CONTROLLED STUDY; CTLA4 GENE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GRAVES DISEASE; HLA DRB1 GENE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN GENE; INTERLEUKIN 10 GENE; INTERLEUKIN 4 GENE; MAJOR CLINICAL STUDY; MALE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22 GENE; POLAND; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA GENE;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HAPLOTYPES; HLA-DRB1 CHAINS; HUMANS; IMMUNITY; MALE; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875432385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059349     Document Type: Article

References (48)

1. Davies TF, (2007) Really significant genes for autoimmune thyroid disease do not exist- so how can we predict disease. Thyroid 17: 1027-29.
2. Zeitlin AA, Simmonds MJ, Gough SCL, (2007) Genetic developments in autoimmune thyroid disease: an evolutionary process. Clin Endocrinol 68: 671-82.
3. Tomer Y, (2010) Genetic susceptibility to autoimmune thyroid disease: past, present and future. Thyroid 7: 715-25.
4. Rioux JD, Abbas AK, (2005) Paths to understanding the genetic basis of autoimmune disease. Nature 435: 584-9.
5. Prummel MF, Strieder T, Wiersinga WM, (2004) The environment and autoimmune thyroid diseases. Europ J Endocrinol 150: 605-18.
6. Tomer Y, Menconi F, Davies TF, Barbesino G, Rocchi R, et al. (2007) Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun 29: 69-77.
7. Hemminki K, Li X, Sundquist J, Sundquist K, (2010) The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 34: J307-13.
8. Segni M, Wood J, Pucarelli I, Toscano V, Toscano R et al. (2001) Clustering of autoimmune thyroid diseases in children and adolescent: a study of 66 families. J Pediatr Endocrinol 14 Supl 5: 1271-5; discussion 1297-8.
9. Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, et al. (2008) Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol & Metabolism 91: 4873-880.
10. Bossowski AT, Reddy V, Perry LA, Johnston LB, Banerjee K, et al. (2007) Clinical and endocrine features and long-term outcome of Graves' disease in early childhood. J Endocrinol Invest 30: 388-92.
11. Vos XG, Smit N, Endert E, Tijssen JG, Wiersinga WM, (2009) Variation in phenotypic appearance of Graves' disease: effect of genetic anticipation and duration of complaints. Europ J Endocrinol 16: 113-8.
12. Perrild H, Lavard L, Brock-Jacobsen B, (1997) Clinical aspects and treatment of juvenile Graves' disease. Exp Clin Endocrinol Diabetes 105Suppl 4: 55-7.
13. Tomer Y, Huber A, (2009) The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 32: 231-9.
14. Khalilzadeh O, Anvari M, Momen-Heravi F, Esteghamati A, Rashidi A, et al. (2010) Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves' disease. Clin Exp Med 10(2): 123-8.
15. O'Sullivan B, Thompson A, Thomas R, (2007) NF-kappa B as a therapeutic target in autoimmune disease. Expert Opin Ther Targets 11: 111-22.
16. Kula D, Bednarczuk T, Jurecka-Lubieniecka B, Polanska J, Hasse-Lazar K, et al. (2006) Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07. Thyroid 16: 447-53.
17. Bednarczuk T, Hiromatsu Y, Seki N, Płoski R, Fukutani T, et al. (2004) Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy. Hum Immunol 65: 632-9.
18. Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, et al. (2003) Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur J Endocrinol 148: 13-8.
19. Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, Kula D, Kowalska M, et al. (2007) Association of NFKB1-94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease. Genes Immun 8: 532-8.
20. Kurylowicz A, Kula D, Ploski R, Skorka A, Jurecka-Lubieniecka B, et al. (2005) Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease. Thyroid 15: 1119-24.
21. Paterson AD, Kennedy JL, Petronis A, (1996) Evidence for genetic anticipation in non-Mendelian diseases. Am J Hum Genet 59: 264-8.
22. Radstake TR, Barrera P, Albers MJ, Swinkels HL, van de Putte LB, et al. (2001) Genetic anticipation in rheumatoid arthritis in Europe. European Consortium on Rheumatoid Arthritis Families. J Rheumatol 28: 962-7.
23. Cocco E, Sardu C, Lai M, Spinicci G, Contu P, et al. (2004) Anticipation of age at onset in multiple sclerosis: a Sardinian cohort study. Neurology 62: 1794-8.
24. Brix TH, Petersen HC, Iachine I, Hegedus L, (2003) Preliminary evidence of genetic anticipation in Graves' disease. Thyroid 13: 447-51.
25. Sawai Y, DeGroot J, (2000) Binding of human thyrotropin receptor peptides to a Graves' disease - predisposing human leukocite antigen class II molecule. J Clin Endocrinol & Metabolism 85: 1176.
26. Ban Y, Davies TF, Greenberg DA, Conception ES, Osman R, et al. (2004) Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun 5: 203-8.
27. Lavard L, Madsen HO, Perrild H, Jacobsen BB, Svejgaard A, (1997) HLA class II associations in juvenile Graves' disease: indication of a strong protective role of the DRB1*0701,DQA1*0201 haplotype. Tissue Antigens 50: 639-41.
28. Farid NR, Stone E, Johnson G, (1980) Graves' disease and HLA: clinical and epidemiologic association. Clin Endocrinol (Oxf) 13: 535-44.
29. Wong GW, Cheng SH, Dorman JS, (1999) The HLA-DQ associations with Graves' disease in Chinese children. Clin Endocrinol (Oxf) 50: 493-5.
30. Onuma H, Ota M, Sugenoya A, Inoko H, (1994) Association of HLA-DPB1*0501 with early-onset Graves" disease in Japanese. Hum Immunol 39: 195-201.
31. Weetman AP, So AK, Warner CA, Foroni L, Fells P, et al. (1988) Immunogenetics of Graves' ophtalmopathy. Clin. Endocrinol (Oxf) 28(6): 619-28.
32. Allahabadia A, Heward JM, Nithiyanathan R, Gibson SM, Reuser TTQ, et al. (2001) MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet 358: 984-985.
33. Frecker M, Stenszky V, Balazs C, Kozma L, Kraszits E, et al. (1986) Genetic factors in Graves' ophthalmopathy. Clin Endocrinol 25: 479-85.
34. Farid NR, Balazs C, (1998) The genetic of thyroid associated ophthalmopathy. Thyroid 8: 407-9.
35. Yin X, Latif R, Bahn R, Davies TF, (2012) Genetic profiling in Graves' disease: further evidence for lack of distinct genetic contribution to Graves' ophthalmopathy. Thyroid 22: 730-6.
36. Krassas GE, Segni M, Wiersinga WM, (2005) Childhood Graves' ophthalmopathy: resulf a European questionaire study. Europ J Endocrinol 153: 515-20.
37. Chan W, Wong GWK, Fan DSP, Cheng ACK, Lam DSC, et al. (2002) Ophthalmopathy in childhood Graves' disease. Br J Ophthalmol 86: 740-42.
38. Goldstein MG, Katowitz WR, Moshang T, Katowitz JA, (2008) Pediatric Thyroid-Associated Orbitopathy: The Children's Hospital of Philadelphia Experience and Literature Review. Thyroid 9: 997-9.
39. Godakos AI, Boboridis K, Krassas GE (2010) Pediatric aspects in Graves' orbitopathy. Pediatr Endocrinol Rev 7 Suppl 2Ł234+44.
40. Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, et al. (2000) Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid 10: 791-6.
41. Bednarczuk T, Gopinath B, Ploski R, Wall JR, (2007) Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol 67: 3-19.
42. Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ, (2000) Primary role of the HLA class II DRB1*0301 allele in Graves Disease. Am J Med Genet 95(5): 432-7.
43. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, et al. (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165: 6606-11.
44. Ueda H, Howson JM, Esposito L, Heward J, Snook H, et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-11.
45. Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, et al. (2007) Cytotoxic T-lymphocyte associated antigen 4 gene polymorphism and autoimmune thyroid disease. J Clin Endocrinol & Metabolism 92(8): 3162-70.
46. Simmonds MJ, Heward JM, Howson JM, Foxall H, Nithiyananthan R, et al. (2004) A systematic approach to the assessment of known TNF-alpha polymorphism in Graves' disease. Genes Immun 5: 267-73.
47. Hunt PJ, Marshall SE, Weetman AP, Bunce M, Bell JI, et al. (2001) Histocompatibility leukocite antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin Endocrinol (Oxf) 55: 491.
48. Heward JM, Brand OJ, Barrett JC, Carr-Smith JD, Franklyn JA, et al. (2007) Association of PTPN22 haplotypes with Graves' disease. J Clin Endocrinol & Metabolism 92(2): 685-690.